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Abstract
In order to determine if the novel influenza A(H1N1)pdm09 was
associated with temporal trends of main serotypes causing
invasive pneumococcal disease (IPD), we studied 384 episodes
of IPD in <18-year-old patients from 2007 to 2012. The number
of IPD episodes diagnosed during the 2009 pandemic period
meant almost one-third of all the episodes diagnosed in the five
included influenza periods (51/156). The number of IPD episodes
diagnosed during the 2009 pandemic period meant almost
one-third of all the episodes diagnosed in the five included
influenza periods. Most of them occurred in <5-year-old children.
Serotype 1 was the main serotype detected over the period,
except for the 2009 pandemic, when it practically disappeared.
Seasonality and viral infections could trigger temporal trends of
serotypes causing IPD.
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Concomitant detection of respiratory viruses occurs often
among children <5 years old with invasive pneumococcal
disease (IPD) [1]. Previous epidemiological studies have also
reported a seasonal association of the epidemic peaks of both
respiratory viral infection and pneumococcal pneumonia [2,3].
The effect of viral infection as facilitator of IPD could be
different according to the attack rate of serotypes [1]. Some of
these pneumococcal serotypes have low invasive capacity and
are frequently detected in carriers. In contrast, there are
serotypes with high invasive capacity that are seldom detected
in carriers but often cause IPD [4,5].
The main serotypes causing IPD have changed over time.
Serotypes 1 and 19A had been considered as emerging
serotypes during the past years in our setting [6,7]. The 2009
pandemics offered the opportunity to analyse whether a high
penetration of a respiratory virus traditionally associated with
IPD [3,8] could have some effects on the distribution of
serotypes causing IPD.
This study included all patients <18 years old with IPD who
attended a tertiary care paediatric hospital, from week 40 of
2007 to week 39 of 2012. A detailed description of our
institution and the geographical area has been reported
elsewhere [6]. Demographic and clinical variables were pro-
spectively collected. IPD was defined as the presence of clinical
findings of infection together with isolation of S. pneumoniae
and/or DNA detection of the pneumolysin gene and an
additional capsular gene, the wzg (CpsA), by real-time polymer-
ase chain reaction (PCR) in any sterile fluid. All pneumococcal
isolates were identified by standard microbiological methods.
Serotyping of strains isolated by culture was carried out by the
Quellung reaction at the National Center for Microbiology
(Majadahonda, Madrid). Detection of pneumococcal serotypes
in negative culture clinical samples was performed at our
laboratory, according to a published Multiplex real-time PCR
methodology [1]. Serotypes were classified as serotypes with
high invasive capacity (1, 4, 5, 7F, 9V, 14, 18C and 19A) and with
low invasive capacity (all others) according to the classification
of Brueggemann and Sleeman [4,5].
Data from the Microbiological Catalan Notification System
[9] was used in order to define the beginning of each influenza
epidemic period, defined as a 3-month period (influenza
quarter). The week of the beginning of the influenza quarter
was considered to be the one when the rate of influenza-like
illness was ≥100/100.000 inhabitants.
The study was approved by the institutional ethics com-
mittee and written informed consent was obtained from all
included patients.
We report 384 episodes of IPD, among 381 patients. Two
hundred and seven (53.9%) of the episodes occurred in male
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patients. The median age was 36.2 months (IQR, 20.1–59.5);
122 (31.8%) were <2 years old, 169 (44.0%) were 2–5 years old
and 93 (24.2%) were ≥5 years old. Pneumonia was the main
clinical manifestation (308, 80.1%), followed by meningitis (37,
9.6%) and bacteraemia/sepsis (35, 9.1%). One hundred (66.7%)
of the pneumonias were complicated pneumonia cases (mainly
with empyema). Data on pneumococcal conjugated vaccination
was available for 377 patients, of whom 122 (32.4%) were
correctly vaccinated for age with PCV7, 32 (8.4%) with PCV10
and 31 (8.1%) with PCV13. Of 384 cases, 117 (30.4%) were
diagnosed by culture and the remaining by real-time PCR.
Figure 1 shows the evolution of episodes of IPD during the
study period. One hundred and fifty-six (40.6%) episodes of
IPD occurred within influenza quarters; 51 of them (32.7%),
were diagnosed during the 2009 pandemic influenza quarter.
Table 1 shows the epidemiological, clinical and microbiological
characteristics of IPD according to each influenza season. For
the 2009 pandemic influenza quarter, the rate of IPD episodes
caused by serotype 1 was significantly lower than in the
pre-pandemic influenza outbreaks (p <0.01) and it remained
very low during the period that spanned the initiation of the
2009 pandemics to the following influenza season. For the first
post-pandemic season (2010–2011), when the A(H1N1)pdm09
was also the main transmitted influenza subtype, the rate of
IPD episodes caused by serotype 1 was again similar to the two
pre-pandemic influenza seasons (25.6% vs. 23.9%, p 0.87).
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FIG. 1. Serotype distribution in children
with invasive pneumococcal disease (IPD)
admitted to Hospital Sant Joan de Deu
(Barcelona) in the 2007–2008 to 2011–
2012 influenza seasons. *Serotypes 4, 5,
7F, 9V, 14, 18C and 19A. †All other
serotypes.
TABLE 1. Epidemiological, clinical and microbiological characteristics of IPD in children diagnosed during the influenza epidemic
periodsa
The pre-pandemic
(2007–08 and 2008–09)
seasons
The pandemic
(2009–10) season
The post-pandemic
(2010–11 and 2011–12)
seasons
The 2009 pandemic vs.
Pre-pandemic
seasons, p
Post-pandemic
seasons, p
Total IPD episodes 46 51 59
Age
0–2 years 11 (23.9%) 17 (33.3%) 18 (30.5%)
2–5 years 20 (43.5%) 19 (37.2%) 27 (45.8%)
>5 years 15 (32.6%) 15 (29.5%) 14 (23.7%)
Median age (months) 41.8 (IQR, 24.7–64.5) 41.6 (IQR, 16.5–61.8) 34.4 (IQR: 16.9–59.3) 0.52 0.66
Sex
Male 23 (50.0%) 29 (56.9%) 32 (54.2%) 0.50 0.78
Female 23 (50.0%) 22 (43.1%) 27 (43.8%)
Main clinical manifestations
Non-complicated pneumonia 10 (21.7%) 19 (37.2%) 18 (30.5%) 0.09 0.46
Complicated pneumonia 28 (60.9%) 25 (49%) 30 (50.8%) 0.24 0.85
Meningitis 7 (15.2%) 3 (5.8%) 6 (10.2%) 0.18 0.50
Bacteraemia/sepsis 1 (2.2%) 4 (7.8%) 4 (6.8%) 0.36 1.00
Pneumococcal serotype
Serotype 1 11 (23.9%) 2 (3.9%) 15 (25.4%) <0.01 <0.01
Serotype 19A 3 (6.5%) 8 (15.7%) 7 (11.9%) 0.15 0.56
High invasive capacity serotypesb 6 (13.0%) 7 (13.7%) 6 (10.2%) 0.93 0.59
Low invasive capacity serotypes 26 (56.6%) 34 (66.6%) 31 (52.5%) 0.30 0.13
Seasonality Winter Autumn Winter
Statistically significant values are marked in bold.
aMain circulating influenza viruses were: pre-pandemic A (H1N1) and B viruses for 2007–2008 and 2008–2009 seasons, the A (H1N1) pdm09 for 2009–2010 and 2010–2011
seasons, and A (H3N2) viruses for the 2011–2012 season.
bOther serotypes with high invasive capacity: 4, 5, 7F, 9V, 14 and 18C.
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Our results with regard to serotype 1 are very intriguing,
because serotype 1 had been the main emergent serotype
together with serotype 19A in our geographical area in the
years before the pandemics [6,8]. In another series, Flem-
ing-Dutra et al. [10] compared IPD rates during peak pandemic
months with mean IPD rates in pre-pandemic years in the
USA. The main serotype detected in <5-year-old patients was
19A, similar to our observations. However, serotype 1 has
been a minority serotype in the United States before and after
the 2009 pandemics, so they cannot describe any impact of
influenza with regard to this serotype.
A possible explanation for the decrease of serotype 1 during
the 2009 pandemic quarter could be that the influenza virus
facilitates invasion by pneumococcus, and maybe the high
penetration of the viral infection during the pandemics could
help those serotypes often detected in carriers to make its
invasiveness more likely [1]. Maybe the impact of this viral
infection as facilitator of IPD was deleterious for serotype 1,
because it is a very bad colonizer. Moreover, the highest
prevalence of pneumococcal carriage has been described in
autumn in several studies [11,12]. Influenza seasons started
during the winter in our setting, except for the 2009 pandemics,
when the peak of incidence of infection was observed in
autumn. The earlier pandemic virus circulation was also
associated with a significant decline of the number of infections
due to respiratory syncytial virus (RSV) [10,13]; that is, another
respiratory virus often associated with peaks of IPD [13] and,
specifically, pneumococcal pneumonia [12] often caused by
serotype 1 in our setting [7]. Recently, influenza has also been
associated with IPD caused by serotypes with a lower invasive
capacity among healthy adults [14].
A subtype-serotype-specific relationship is improbable
because serotype 1 re-emerged in the first post-pandemic
season, when the A(H1N1)pdm09 influenza virus was again the
main circulating subtype.
To conclude, the proportion of IPD episodes caused by
serotype 1 during the 2009 pandemics was significantly lower
than in the pre-pandemic period and it remained very low
during the period that spanned the initiation of the 2009
pandemics to the following influenza season, when it started to
increase again. Seasonality and viral infections could trigger
temporal trends of the main serotypes causing IPD.
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